Log In
Print
BCIQ
Print
Print this Print this
 

Azactam, aztreonam

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionIV formulation of aztreonam
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationGram-negative bacterial infection
Indication DetailsTreat Gram-negative bacterial infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today